Living donor liver transplantation for patients with hepatitis C virus cirrhosis: Tokyo experience

Clinical Gastroenterology and Hepatology

Volumn 3, Issue SUPPL. 2, 2005, Pages

  Sugawara, Yasuhiko ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN;

CLINICAL TRIAL; CONFERENCE PAPER; DEATH; DEPRESSION; FATIGUE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; KIDNEY DISEASE; KIDNEY DONOR; LEUKOPENIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; RNA ANALYSIS; THROMBOCYTOPENIA;

ADULT; AGED; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 26444538489     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-3565(05)00708-1     Document Type: Conference Paper

References (12)

1. Data from European Liver Transplant Registry. Available at: http://www.eltr.org/publi/index_rv.php3. Accessed April 12, 2005.
2. Data from Organ procurement and transplantation network. Available at: http://www.optn.org/latestData/advancedData.asp. Accessed April 12, 2005.
3. The Japanese Liver Transplantation Society Liver transplantation in Japan registry by the Japanese Liver Transplantation Society (in Japanese) Jpn J Transplant 39 2004 634 642
4. Y. Sugawara, M. Makuuchi, K. Sano Vein reconstruction in modified right liver graft for living donor liver transplantation Ann Surg 237 2003 180 185
5. Y. Sugawara, M. Makuuchi, J. Kaneko Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation Clin Transplant 16 2002 102 106
6. G. Yamada, M. Takatani, F. Kishi Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level Hepatology 22 1995 1351 1354
7. D. Samuel Hepatitis C, interferon, and risk of rejection after liver transplantation Liver Transpl 10 2004 868 871
8. V. Mazzaferro, A. Tagger, M. Schiavo Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment Transplant Proc 33 2001 1355 1357
9. V. Mazzaferro, M. Schiavo, L. Caccamo Prospective randomized trial on early treatment of HCV infection after liver transplantation in HCV RNA positive patients (abstract) Liver Transpl 9 2003 C-36
10. Y. Sugawara, M. Makuuchi Should living donor liver transplantation be offered to patients with hepatitis C virus cirrhosis? J Hepatol 42 2005 472 475
11. P.J. Gaglio, S. Malireddy, B.S. Levitt Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors Liver Transpl 9 2003 1028 1035
12. M.W. Russo, R. Shrestha Is severe recurrent hepatitis C more common after adult living donor liver transplantation? Hepatology 40 2004 524 526